Abstract
The possibility and possible aetiology of local prostate cancer (PC) recurrence despite undetectable prostate-specific antigen (PSA) levels are highlighted. A case of a local recurrence 8.5 years after radical prostatectomy for Gleason 3+4 PC is presented. It demonstrates that PC can recur, even after a prolonged period of time (8.5 years), despite undetectable levels (i.e. <0.02 ng/ml) of PSA. In conclusion, the decision to omit digital rectal examination from the follow-up regimens of men with undetectable PSA levels could be justified. In such exceptional cases, however, PC recurrence would be either missed or would only be diagnosed after a considerable delay.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E . Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909–916.
Oh J, Colberg JW, Ornstein DK, Johnson ET, Chan D, Virgo KS et al. Current follow up strategies after radical prostatectomy: a survey of American Urological Association Urologists. J Urol 1999; 161: 520–523.
Pound CR, Christens-Barry OW, Gurganus RT, Partin AW, Walsh PC . Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy. J Urol 1999; 162: 1337–1340.
Gleason DF . Histologic grading of prostate cancer: a perspective. Hum Pathol 1992; 23: 273–279.
Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M . The TNM classification of prostate cancer. Prostate Suppl 1992; 4: 129–138.
Goldrath DE, Messing EM . Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy. J Urol 1989; 142: 1082–1084.
Oefelein MG, Smith N, Carter M, Dalton D, Schaeffer A . The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies. J Urol 1995; 154: 2128–2131.
Chaplin BJ, Wildhagen MF, Schroder FH, Kirkels WJ, Bangma CH . Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up. Eur Urol 2005; 48: 906–910.
Leibman BD, Dillioglugil O, Wheeler TM, Scardino PT . Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen level. Cancer 1995; 76: 2530–2534.
Takayama TK, Krieger JN, True LD, Lange PH . Recurrent prostate cancer despite undetectable prostate specific antigen. J Urol 1992; 148: 1541–1542.
Stege RH, Tribukait B, Carlstrom KA, Grande M, Pousette AH . Tissue PSA from fine-needle biopsies of prostatic carcinoma as related to serum PSA, clinical stage, cytological grade, and DNA ploidy. Prostate 1999; 38: 183–188.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roemeling, S., van Leenders, G. & Schröder, F. Very late local recurrence after surgery for prostate cancer unaccompanied by detectable PSA levels. Prostate Cancer Prostatic Dis 9, 192–194 (2006). https://doi.org/10.1038/sj.pcan.4500861
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500861